<DOC>
	<DOCNO>NCT01858753</DOCNO>
	<brief_summary>This Phase II , double-blind , randomize , placebo-controlled pilot study design determine whether injection autologous fibroblast increase mobility ( decrease restriction ) burn scar . The study assess effect azficel-T ( autologous fibroblast ) subject unilateral burn scar deeper fascia ( i.e. , underlie structure include ligament , tendon , muscle , bone must contribute restriction ) either : 1 . An axillary scar cause 20-60 % restriction shoulder adduction 2 . An anterior elbow scar cause 20-60 % restriction elbow extension 3 . A dorsal palmar lesion single finger cause 20-60 % restriction flexion extension Subjects receive 2 injection azficel-T placebo administer 14 day ( ± 7 day ) apart ( depend cell availability ) follow efficacy ( include range motion measurement , scar pain ability perform activity ) Visit 7 safety Visit 9 1 year .</brief_summary>
	<brief_title>Pilot Study Azficel-T Treatment Restrictive Burn Scars</brief_title>
	<detailed_description />
	<mesh_term>Burns</mesh_term>
	<mesh_term>Cicatrix</mesh_term>
	<criteria>1 . Subject least 18 year age 2 . Subject unilateral burn scar joint area ( i.e. , finger , elbow , shoulder ) deep fascia ( i.e. , underlie structure include ligament , tendon , muscle , bone must contribute restriction ) either : 1 . An axillary scar cause 2060 % restriction shoulder abduction 2 . An anterior elbow scar cause 2060 % restriction elbow extension 3 . A dorsal palmar lesion single finger cause 2060 % restriction flexion extension 3 . Subject 's burn scar treat &lt; 100 sq cm size 4 . Injury occur ≤ 36 month prior screen 5 . By Investigator 's assessment , physical therapy provide significant continuous improvement range motion subject 's joint 6 . Subject agree maintain current physical therapy regimen duration study 7 . Subject must able provide write informed consent comply study requirement 8 . Females childbearing potential must negative urine pregnancy test screen visit prior first treatment , must agree use reliable mean birth control duration study 9 . Subject healthy , nonscarred post auricular skin area suitable biopsy 10 . Subject must normal complete blood count ( CBC ) chemistry panel within 90 day prior enrollment 1 . Restrictive burn scar primarily classify keloid scar 2 . Subjects post auricular biopsy collect azficelT production 3 . Sunburn sun damage area use biopsy 4 . Plans initiate new scar therapy study period 5 . Treatment investigational product procedure within 30 day prior study enrollment plan participate another clinical trial course study 6 . History active autoimmune disease organ transplantation 7 . Diagnosis cancer , include basal cell carcinoma , unless successfully treat remission minimum 6 month 8 . Known genetic disorder affect fibroblast collagen , achondroplasia , osteogenesis imperfecta , epidermolysis bullosa , ataxiatelangiectasia , Ehlers Danlos syndrome , etc . 9 . Active systemic infection 10 . Requires chronic antibiotic steroidal therapy 11 . Any condition consider Investigator contraindication biopsy injection 12 . Pregnant lactate woman , woman try become pregnant study 13 . Subject disorder may prevent compliance , history chronic alcohol drug abuse , significant mental nervous disorder illness would , Investigator 's opinion , interfere study 14 . Presence disease condition would result impairment range motion extremity , e.g. , rheumatoid arthritis stroke</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>burn scar</keyword>
	<keyword>restrictive</keyword>
	<keyword>contracture</keyword>
	<keyword>autologous fibroblast</keyword>
</DOC>